Breast cancer is the most common cancer among women, apart from skin cancers. According to the National Breast Cancer Foundation, Inc., about 1 in 8 American women will experience this cancer in their lives. Breast cancer is an incredibly difficult disease to fight or to watch a loved one go through. Raising awareness of the scope and seriousness of this disease is one of the most important and impactful functions of breast cancer events and promotional items. Fundraising events, such as walks and fun runs, have become a common way to raise awareness about this issue and financially support the people and families who have been affected by this disease. Individuals as well as nonprofit organizations like the Susan G. Komen Breast Cancer Foundation and Breastcancer.org have taken it upon themselves to earn money for breast cancer research. One of the slogans often used is, Breast Cancer Awareness Is Not Just a Month.
Welcome to this episode of Physician’s Weekly Podcast. My name is Dr Rachel Giles, from Medicom Medical Publishers, in collaboration with Physician’s Weekly. We have 3 fantastic in-depth interviews for you this week.
Later in this podcast, Physician’s Weekly’s Senior Editor Martta Kelly interviews Dr John Barbieri , Dermatologist at Brigham and Women's Hospital in Boston about cardiovascular risk factors in patients with psoriasis and psoriatic arthritis. We know that patients with psoriasis and psoriatic arthritis have an increased risk of cardiovascular mortality, but are less likely to have traditional cardiovascular risk factors identified and managed. This is a major evidence to practice gap. To improve the prevention of cardiovascular disease in patients with psoriatic disease, Dr Barbiera lays out some pragmatic approaches for physicians.
Also in this podcast, we’re back again this week with Physician’s Weekly regular contributor, known by the pseudonym Dr. MedLaw, a board-certified radiologist and medical malpractice attorney. Today she takes a deep dive in the doctor-patient privilege, what that means, when and how it can be used, and why it is important. Did you know that patient privilege came about as a public health intervention to prevent the spread of venereal disease?
But firstly, in honor of Breast Cancer Awareness Month, today we will kick off our podcast with an interview with Dr. Marco Timmers, the CEO of up-and-coming pharmaceutical company Byondis, who presented their initial data from the phase 3 TULIP trial in breast cancer patients during the Presidental Symposium at the European Society of Medical Oncology, just a few weeks ago. Their new antibody-conjugate drug, called trastuzumab duocarmazine was compared to the physician’s choice for the 3rd line setting in 436 metastatic HER2-positive breast cancer. The results showed impressive efficacy in the initial topline results.